CTOs on the Move

Epocrates

www.epocrates.com

 
Epocrates, Inc. is a provider of clinical information and decision support tools to healthcare professionals, as well as interactive information services to the healthcare industry. As of April 17, 2008, the Company has subscriber base of over 500,000
  • Number of Employees: 250-1000
  • Annual Revenue: > $1 Billion
  • www.epocrates.com
  • 311 Arsenal Street Watertown
    San Mateo, MA USA 02472
  • Phone: 888.807.2076

Executives

Name Title Contact Details

Similar Companies

Intelerad

Improving healthcare through innovative technology is at the core of Intelerad`s work. Our scalable medical imaging platform connects clinicians to a powerful imaging ecosystem that is fast, smart and tapped into the data they need, no matter their location. We`re focused on delivering a best-in-class medical image management solution that improves provider efficiency, decreases the cost of healthcare, and improves the overall health of populations.

Quantum Medical Imaging

Quantum Medical Imaging is a Ronkonkoma, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Stat Medical

Stat Medical is a Kirkland, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Management Specialists

Medical Management Specialists is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Armetheon

Armetheon, Inc. is a privately held San Francisco Bay area-based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases. The company was founded in 2011 by experienced biotech entrepreneurs and drug developers. Armetheon’s two late-stage small molecule drug candidates are for use in the areas of oral anti-coagulation and anti-arrhythmia for atrial fibrillation. The company was founded with the idea that drug innovations can happen by building on the success of proven medications. We create solutions that are within the same class of medication and that utilize the same mechanism of action as existing therapies. This development approach has the ability to offer peace of mind to patients while benefitting physicians, who may wish to reduce safety concerns, side effects and adverse events for their patients.